Drug Therapy
FDA/CDC
Mavyret approved for children with any HCV genotype
Mavyret (glecaprevir and pibrentasvir) tablets are the first means of treating any of six identified genotypes of HCV in children.
FDA/CDC
Benlysta approved for children with SLE
This approval marks the first medicine in the United States meant to treat systemic lupus erythematous in children.
News
Long-term antibiotic use may heighten stroke, CHD risk
Among middle-aged and older women, 2 or more months’ exposure to antibiotics is associated with an increased likelihood of cardiovascular disease...
News
Gaps exist in rotavirus vaccination coverage in young U.S. children
Twenty-nine percent of U.S. children under age 36 months likely are not fully vaccinated against rotavirus vaccine.
News
CDC warns against misuse of opioid-prescribing guideline
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....
FDA/CDC
FDA approves generic naloxone spray for opioid overdose treatment
The agency said the naloxone nasal spray does not need assembly and can be used by anyone, regardless of medical training.
News
Poor response to statins hikes risk of cardiovascular events
Patients with better outcomes were more likely to have initiated therapy with a more potent drug.
News
2018 at a glance: Recently approved therapies in oncology
This article reviews therapies that were newly approved in 2018, as well as those previously approved whose indications were expanded. The list...
Conference Coverage
ACE inhibitors may improve neuropsychiatric lupus
SAN FRANCISCO –
Conference Coverage
Dr. Louis Weiner: AACR presentations highlight new “transformative strategies”
ATLANTA – Studies featured during a press briefing at the AACR annual meeting, including work on a cancer preventive...